Insights On Pharmaceutical Inspection
-
CCIT Comparative Study Between Dye Ingress And Deterministic Methods
1/13/2023
Explore the results of a unique comparative study of CCIT, and find a suitable deterministic test method to replace the blue dye test that follows the latest guidelines.
-
AMI 1000 – An Innovative CCIT Solution For The Pharmaceutical Industry
5/4/2022
This innovative CCIT solution based on Optical Emission Spectroscopy (O.E.S.) is an deterministic test method according to USP 1207 that can be used for in-process control during production or for laboratory purposes.
-
Correlating Stopper Height To Container Closure Integrity
11/21/2023
Learn how to comply with the new EU Annex 1 Section 8.28. Here, we describe a typical raised-stopper investigation and demonstrate how to generate scientifically robust data using headspace analysis.
-
A High Sensitivity Solution For Pharma CCIT
10/26/2022
Experience a comprehensive CCIT solution completely adapted to the needs of pharma customers. The software features intuitive menus, simple navigation, 21 CFR part 11 compliance, traceability, and data storage.
-
Bombing - Leak Test Of Hermetically Sealed Objects
4/28/2022
Learn in detail about the best practice of leak testing of hermetically sealed devices in microelectronics, sensor technology, and other industries.
-
The Golden Tool For Container Closure Integrity Testing
8/17/2023
Discover the power of headspace gas ingress in ensuring product quality. Dr. Derek Duncan, Director of Product Lines, Lighthouse Instruments, reveals the golden tool for container closure integrity testing.
-
Effects Of X-Ray Inspection On Pharmaceutical Products
3/7/2023
Some manufacturers still have reservations about adopting X-ray inspection as a safe method of product inspection. Explore the potential effects of X-ray inspection on pharmaceutical products and more.
-
The Container Closure Integrity Requirements In The Revised EU Annex 1
11/21/2022
Learn about the advantages and disadvantages of CCI testing methods, how the revised EU Annex 1 may impact your strategy for ensuring CCI of sterile pharmaceutical products, and more.
-
Choosing The Right Primary Container And Troubleshooting Issues
8/25/2023
Selecting the right primary container for an injectable drug product is critical. Discover how to identify relevant testing to de-risk your product development – and quickly uncover causes of failures.
-
Innovative Leak Testing Of Pharmaceutical Blister Packages
6/15/2022
Learn how to obtain highly sensitive, quantitative measurements in real-time without specific tracer gases.